E
Sell
2/19/2025Downgrade
Neurogene Inc. (NGNE) was downgraded to E+ from D- on 2/19/2025 due to a noticeable decline in the total return index and volatility index.
D
Sell
1/21/2025Downgrade
Neurogene Inc. (NGNE) was downgraded to D- from D on 1/21/2025 due to a decline in the volatility index and total return index.
D
Sell
1/6/2025Upgraded
Neurogene Inc. (NGNE) was upgraded to D from D- on 01/06/2025.
D
Sell
9/3/2024Upgraded
Neurogene Inc. (NGNE) was upgraded to D- from E+ on 9/3/2024 due to a large increase in the solvency index and total return index.
E
Sell
6/3/2024Upgraded
Neurogene Inc. (NGNE) was upgraded to E+ from E on 06/03/2024.
E
Sell
4/11/2024Downgrade
Neurogene Inc. (NGNE) was downgraded to E from E+ on 4/11/2024 due to a noticeable decline in the volatility index.
E
Sell
3/20/2024Upgraded
Neurogene Inc. (NGNE) was upgraded to E+ from E on 3/20/2024 due to a significant increase in the valuation index, solvency index and growth index. Earnings per share increased from -$2.4695 to $47.2416, the quick ratio increased from 4.9 to 8.61, and EBIT increased 3.19% from -$15.22M to -$14.73M.
E
Sell
3/15/2024None
Neurogene Inc. (NGNE) was downgraded to E from U on 03/15/2024.
